King Bomb
A high-THC hybrid marketed as a heavyweight indica, with lineage claims that don't hold up to scrutiny.
King Bomb is a legitimately potent hybrid sold by a handful of seed banks, but almost everything written about it online — the specific parent strains, the exact THC percentages, the guaranteed 'couch-lock' effect — comes from marketing copy, not verified records. If you find it, expect a strong, sedating high typical of many modern high-THC hybrids. Just don't trust the lineage story or effect promises as if they were facts. They aren't.
Overview
King Bomb is a cannabis strain sold primarily through online seed banks, most notably associated with Bomb Seeds, a breeder in the Bomb Seeds catalog of '-Bomb' branded varieties [1]. It is marketed as an indica-dominant hybrid with high THC and a heavy body effect. Beyond vendor marketing and grower forum posts, there is essentially no independent, peer-reviewed or laboratory-published characterization of this strain No data. Anything presented here about its specific chemistry, effects, or genetics should be read with that caveat in mind.
Like most named strains on the market, 'King Bomb' is a brand more than a stable, verified cultivar. Different phenotypes and reseller versions likely differ meaningfully in both chemistry and effect [2].
Chemistry: cannabinoids and terpenes
Vendor listings put King Bomb's THC in the 20-25% range with negligible CBD [1]. These figures come from breeder self-report, not standardized third-party testing across batches Weak / limited.
No peer-reviewed terpene profile exists for King Bomb specifically. Descriptions in seed-bank copy mention 'earthy,' 'sweet,' and 'hashy' notes, which vaguely suggests myrcene and/or caryophyllene dominance — but this is inference, not measurement No data.
More broadly, research shows that strain names correlate poorly with actual chemical profiles. A 2022 analysis of thousands of commercial cannabis samples found substantial chemical overlap between differently named strains and wide variation within a single strain name [2][3]. Treat any specific number attached to King Bomb as a rough estimate at best.
Reported effects
Users and vendors describe King Bomb as producing strong relaxation, heavy limbs, sleepiness, and appetite stimulation — the standard 'indica-style' descriptor set [1] Anecdote. Some reviews mention euphoria and giggles early in the high transitioning into sedation.
Important caveats:
- There are no clinical trials on King Bomb. Any medical claim about it is extrapolation from general cannabis research, not strain-specific evidence No data.
- The indica vs sativa distinction is not a reliable predictor of effects. Scientific reviews have repeatedly found that these labels don't map cleanly onto chemistry or subjective experience [4][5] Strong evidence.
- High-THC flower in general carries a higher risk of anxiety, paranoia, and, with regular heavy use, cannabis use disorder and cannabinoid hyperemesis syndrome [6] Strong evidence.
If you're sensitive to THC or new to cannabis, treat King Bomb like any other 20%+ THC flower: start with a very small dose.
Lineage (disputed)
Bomb Seeds describes King Bomb as a cross involving a heavy indica and one of their in-house Bomb lines, but the specific parent strains listed vary between the breeder's own site, reseller pages, and aggregator databases [1] Disputed. Common third-party databases like SeedFinder and Leafly list parentage with wording like 'unknown indica' or leave the parents blank.
Because cannabis genetics in the commercial market are almost entirely undocumented — no registry, no verified pedigrees, no genetic testing at the breeder level for most strains — 'lineage' for strains like King Bomb should be understood as marketing narrative rather than fact [2][3]. Academic work on cannabis population genetics has found that strain names frequently don't match the genetic clusters they claim to belong to [3] Strong evidence.
Bottom line: nobody outside the original breeder can confirm what King Bomb actually is genetically, and even the breeder's account isn't independently verifiable.
Cultivation basics
Vendor-reported cultivation notes for King Bomb [1]:
- Flowering time: roughly 8-9 weeks indoors.
- Yield: described as moderate to high; specific gram-per-square-meter numbers are breeder marketing figures, not measured under controlled conditions Weak / limited.
- Height / stretch: typical of indica-leaning hybrids — moderate stretch, dense buds.
- Environment: no specific unusual requirements reported. Standard indoor setups (controlled humidity, adequate airflow, moderate feeding) should work.
- Difficulty: often labeled 'beginner-friendly,' though this is a common marketing claim across most seed catalogs and should be viewed skeptically.
Outdoor performance depends heavily on climate; the breeder recommends temperate to warm growing regions with harvest around late September / early October in the Northern Hemisphere. No independent grow trials appear in the peer-reviewed literature No data.
Marketing vs. reality
Where King Bomb's marketing outruns the evidence:
- 'Indica-dominant, guaranteed couch-lock.' The indica/sativa framework doesn't reliably predict effects [4][5]. Sedation from any high-THC flower depends on dose, individual biology, and terpene profile more than on strain label.
- Specific THC percentages. Vendor-listed potencies are typically best-case lab pulls or breeder estimates. Real-world grows vary widely [2] Strong evidence.
- Detailed parentage. Presented with confidence in some listings, contradicted or absent in others Disputed.
- Medical claims (for pain, insomnia, appetite). These are extrapolations from general cannabis research, not King Bomb-specific data No data.
What's probably true: it's a potent, THC-heavy hybrid that produces a strong, sedating high in most users, like many other modern commercial hybrids. What's marketing: everything more specific than that.
Sources
- Reported Bomb Seeds. Product listings and catalog descriptions for the '-Bomb' strain family, including King Bomb.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 2022;17(5):e0267498.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. The genetic structure of marijuana and hemp. PLOS ONE, 2015;10(8):e0133292.
- Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 2016;1(1):44-46.
- Peer-reviewed Watts S, McElroy M, Migicovsky Z, Maassen H, van Velzen R, Myles S. Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 2021;7:1330-1334.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: National Academies Press, 2017.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Cannabis Use Disorder — A real DSM-5 diagnosis affecting roughly 1 in 5 regular users, with modest but growing evi...
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...